Latest & greatest articles for fibromyalgia

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on fibromyalgia or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on fibromyalgia and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for fibromyalgia

141. Gabapentin for fibromyalgia pain in adults [Cochrane Protocol]

Gabapentin for fibromyalgia pain in adults [Cochrane Protocol] Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing and effect measures Timing

2016 PROSPERO

142. Prevalence of fibromyalgia and co-morbidity with depression, anxiety, and other disorders

Prevalence of fibromyalgia and co-morbidity with depression, anxiety, and other disorders Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing

2016 PROSPERO

143. Oral nonsteroidal anti-inflammatory drugs for fibromyalgia in adults [Cochrane Protocol]

Oral nonsteroidal anti-inflammatory drugs for fibromyalgia in adults [Cochrane Protocol] Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing

2016 PROSPERO

144. Milnacipran for pain in fibromyalgia in adults. Full Text available with Trip Pro

Milnacipran for pain in fibromyalgia in adults. This is an updated version of the original Cochrane review published in Issue 3, 2012. That review considered both fibromyalgia and neuropathic pain, but the efficacy of milnacipran for neuropathic pain is now dealt with in a separate review.Milnacipran is a serotonin-norepinephrine (noradrenaline) reuptake inhibitor (SNRI) that is licensed for the treatment of fibromyalgia in some countries, including Canada, Russia, and the United States.To (...) assess the analgesic efficacy of milnacipran for pain in fibromyalgia in adults and the adverse events associated with its use in clinical trials.We searched the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, and EMBASE to 18 May 2015, together with reference lists of retrieved papers and reviews, and two clinical trial registries. For the earlier review, we also contacted the manufacturer.We included randomised, double-blind studies of eight weeks' duration or longer, comparing

2015 Cochrane

145. New Approach in Fibromyalgia Exercise Program: A Preliminary Study Regarding the Effectiveness of Balance Training (Abstract)

New Approach in Fibromyalgia Exercise Program: A Preliminary Study Regarding the Effectiveness of Balance Training To determine the effectiveness of balance exercises on the functional level and quality of life (QOL) of patients with fibromyalgia syndrome (FMS) and to investigate the circumstances associated with balance disorders in FMS.Randomized controlled trial.Physical medicine and rehabilitation clinic.Patients (N=57) (age range, 18-65y) with FMS were randomly assigned into 2 groups.Group (...) 1 was given flexibility and balance exercises for 6 weeks, whereas group 2 received only a flexibility program as the control group.Functional balance was measured by the Berg Balance Scale (BBS), and dynamic and static balance were evaluated by a kinesthetic ability trainer (KAT) device. Fall risk was assessed with the Hendrich II fall risk model. The Nottingham Health Profile, Fibromyalgia Impact Questionnaire (FIQ), and Beck Depression Inventory (BDI) were used to determine QOL and functional

2015 EvidenceUpdates Controlled trial quality: uncertain

146. Selective serotonin reuptake inhibitors for fibromyalgia syndrome. Full Text available with Trip Pro

Selective serotonin reuptake inhibitors for fibromyalgia syndrome. Fibromyalgia is a clinically well-defined chronic condition with a biopsychosocial aetiology. Fibromyalgia is characterized by chronic widespread musculoskeletal pain, sleep problems, cognitive dysfunction, and fatigue. Patients often report high disability levels and poor quality of life. Since there is no specific treatment that alters the pathogenesis of fibromyalgia, drug therapy focuses on pain reduction and improvement (...) of other aversive symptoms.The objective was to assess the benefits and harms of selective serotonin reuptake inhibitors (SSRIs) in the treatment of fibromyalgia.We searched the Cochrane Central Register of Controlled Trials (CENTRAL; 2014, Issue 5), MEDLINE (1966 to June 2014), EMBASE (1946 to June 2014), and the reference lists of reviewed articles.We selected all randomized, double-blind trials of SSRIs used for the treatment of fibromyalgia symptoms in adult participants. We considered

2015 Cochrane

147. Treatments for Fibromyalgia in Adult Subgroups

Treatments for Fibromyalgia in Adult Subgroups Treatments for Fibromyalgia in Adult Subgroups Treatments for Fibromyalgia in Adult Subgroups Forte ML, Butler M, Andrade KE, Vincent A, Schousboe JT, Kane RL Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Forte ML, Butler M, Andrade KE, Vincent A, Schousboe JT, Kane RL. Treatments (...) for Fibromyalgia in Adult Subgroups. Rockville: Agency for Healthcare Research and Quality (AHRQ). Comparative Effectiveness Review No. 148. 2015 Authors' objectives We searched MEDLINE, EMBASE, PsycINFO, AMED, and the Cochrane Central Register of Controlled Trials (CENTRAL) plus reference lists of included studies and recent systematic reviews. Authors' conclusions Despite the prevalent belief that fibromyalgia treatments may behave differently in subgroups, evidence to date is largely insufficient

2015 Health Technology Assessment (HTA) Database.

148. Mind and body therapy for fibromyalgia. (Abstract)

Mind and body therapy for fibromyalgia. Mind-body interventions are based on the holistic principle that mind, body and behaviour are all interconnected. Mind-body interventions incorporate strategies that are thought to improve psychological and physical well-being, aim to allow patients to take an active role in their treatment, and promote people's ability to cope. Mind-body interventions are widely used by people with fibromyalgia to help manage their symptoms and improve well-being (...) . Examples of mind-body therapies include psychological therapies, biofeedback, mindfulness, movement therapies and relaxation strategies.To review the benefits and harms of mind-body therapies in comparison to standard care and attention placebo control groups for adults with fibromyalgia, post-intervention and at three and six month follow-up.Electronic searches of the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE (Ovid), EMBASE (Ovid), PsycINFO (Ovid), AMED (EBSCO) and CINAHL (Ovid

2015 Cochrane

149. Treatments for Fibromyalgia in Adult Subgroups

Treatments for Fibromyalgia in Adult Subgroups Treatments for Fibromyalgia in Adult Subgroups Comparative Effectiveness Review Number 148Comparative Effectiveness Review Number 148 Treatments for Fibromyalgia in Adult Subgroups Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 540 Gaither Road Rockville, MD 20850 www.ahrq.gov Contract No. 290-2012-00016-I Prepared by: Minnesota Evidence-based Practice Center Minneapolis, MN Investigators: Mary (...) without special permission. Citation of the source is appreciated. Persons using assistive technology may not be able to fully access information in this report. For assistance, contact EffectiveHealthCare@ahrq.hhs.gov. None of the investigators have any affiliations or financial involvement that conflict with the material presented in this report. Suggested citation: Forte ML, Butler M, Andrade KE, Vincent A, Schousboe JT, Kane RL. Treatments for Fibromyalgia in Adult Subgroups. Comparative

2015 Effective Health Care Program (AHRQ)

150. Fibromyalgia clinical practice guidelines: a global comparison

Fibromyalgia clinical practice guidelines: a global comparison Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing and effect measures Timing

2015 PROSPERO

151. Pregabalin for pain in fibromyalgia in adults [Cochrane Protocol]

Pregabalin for pain in fibromyalgia in adults [Cochrane Protocol] Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing and effect measures

2015 PROSPERO

152. Predictors associated with the onset of fibromyalgia/chronic widespread pain: meta-analysis and systematic review

Predictors associated with the onset of fibromyalgia/chronic widespread pain: meta-analysis and systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence

2015 PROSPERO

153. Vitamin and mineral status in chronic fatigue syndrome and fibromyalgia syndrome patients: a systematic review

Vitamin and mineral status in chronic fatigue syndrome and fibromyalgia syndrome patients: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence

2015 PROSPERO

154. The use of cannabinoids in fibromyalgia: a systematic review

The use of cannabinoids in fibromyalgia: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing and effect measures Timing

2015 PROSPERO

155. The relationship between pain thresholds and catastrophizing, fear, anxiety and illness perceptions in patients with fibromyalgia compared with healthy people, a systematic review

The relationship between pain thresholds and catastrophizing, fear, anxiety and illness perceptions in patients with fibromyalgia compared with healthy people, a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email

2015 PROSPERO

156. Effectiveness of cognitive-behavioral therapy for the treatment of insomnia in patients with fibromyalgia: a systematic review

Effectiveness of cognitive-behavioral therapy for the treatment of insomnia in patients with fibromyalgia: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne

2015 PROSPERO

157. Whole body vibration exercise for fibromyalgia [Cochrane Protocol]

Whole body vibration exercise for fibromyalgia [Cochrane Protocol] Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing and effect measures

2015 PROSPERO

158. Cannabinoids for fibromyalgia [Cochrane Protocol]

Cannabinoids for fibromyalgia [Cochrane Protocol] Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing and effect measures Timing and effect

2015 PROSPERO

159. Antipsychotics for fibromyalgia [Cochrane Protocol]

Antipsychotics for fibromyalgia [Cochrane Protocol] Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing and effect measures Timing and effect

2015 PROSPERO

160. Effects of cranial electrical stimulation on activity in regions of the basal ganglia in individuals with fibromyalgia. (Abstract)

Effects of cranial electrical stimulation on activity in regions of the basal ganglia in individuals with fibromyalgia. 24571578 2014 11 07 2014 03 06 1557-7708 20 3 2014 Mar Journal of alternative and complementary medicine (New York, N.Y.) J Altern Complement Med Effects of cranial electrical stimulation on activity in regions of the basal ganglia in individuals with fibromyalgia. 206-7 10.1089/acm.2014.1501 Anderson Joel G JG 1 Center for the Study of Complementary and Alternative Therapies (...) , University of Virginia , Charlottesville, VA. Kebaish Samy A SA Lewis Janet E JE Taylor Ann Gill AG eng Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't 2014 02 26 United States J Altern Complement Med 9508124 1075-5535 IM Basal Ganglia physiopathology Electric Stimulation Therapy methods Fibromyalgia physiopathology therapy Humans Magnetic Resonance Imaging 2014 2 28 6 0 2014 2 28 6 0 2014 11 8 6 0 ppublish 24571578 10.1089/acm.2014.1501

2014 Journal of alternative and complementary medicine (New York, N.Y.) Controlled trial quality: uncertain